Results 71 to 80 of about 154 (98)

Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin. [PDF]

Ther Deliv
Kumar G, Jain P, Virmani T, Sharma A, Akhtar MS, Aldosari SA, Khan MF, Duarte SOD, Fonte P.   +8 more
europepmc   +1 more source

Revitalizing Colchicine: Novel Delivery Platforms and Derivatives to Expand Its Therapeutic Potential. [PDF]

Int J Mol Sci
Dubashynskaya NV, Bokatyi AN, Galagudza MM, Skorik YA.   +3 more
europepmc   +1 more source

Zaleplon nanospanlastics loaded transdermal patches: formulation, optimization, ex-vivo permeation, and in-vivo studies. [PDF]

J Pharm Pharm Sci
El-Shenawy AA, Abd Elkarim RA, Mahmoud RA, Ramadan AEH, Alamri AH, Abdelkader H, Elafify MS, Mahmoud EA, Saddik MS, Mohamed MS.   +9 more
europepmc   +1 more source

Ethosome-Based Transdermal Drug Delivery: Its Structural Components, Preparation Techniques, and Therapeutic Applications Across Metabolic, Chronic, and Oncological Conditions. [PDF]

Pharmaceutics
Almuqbil RM, Aldhubiab B.
europepmc   +1 more source

Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery. [PDF]

Pharmaceutics
Brito S, Baek M, Bin BH.
europepmc   +1 more source

Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery. [PDF]

Pharmaceuticals (Basel)
Batur E, Özdemir S, Durgun ME, Özsoy Y.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Development and Characterization of Apremilast Transethosomal Gel for Transdermal Delivery

International Journal of Pharmaceutical Sciences and Nanotechnology, 2021
The apremilast is anti-inflammatory drug and PDE-4 inhibitor, used in treatment of psoriasis. The oral route of apremilast has limitation of GI irritation and frequent dosage regimen.The objective of the present work was aimed to prepare transethosomal gel of apremilast to achieve more skin permeation, more drug entrapment efficiency and sustained ...
Mrunal Rahangdale, Prachi Pandey
openaire   +1 more source

Development and optimization of cilostazol loaded transethosomal gel for improved performance

Pharmaceutical Development and Technology
Deep vein thrombosis (DVT) is the third major leading cause of mortality and morbidity after cardiovascular disease and stroke. Cilostazol (CLZ) being one of the antiplatelet agents is effectively used in DVT. However, its oral administration is associated with several problems, such as gastrointestinal side effects and extensive first-pass metabolism.
Saba Sohail, Ali H Alamri, Ahmed A Lahiq   +2 more
exaly   +3 more sources

Development and optimization of transethosomal gel of apigenin for topical delivery: In-vitro, ex-vivo and cell line assessment

International Journal of Pharmaceutics, 2023
The main aim of this study was to optimize the transethosomes of apigenin formulated by the thin film hydration method using surfactant Span 80. Response surface Box-Behnken design with three levels of three factors was used to design and optimize the formulations.
Obaid Afzal, Abdulmalik S A Altamimi, Mubarak A Alamri   +2 more
exaly   +3 more sources

“Development and Optimization of Nimesulide Loaded Transethosomal Gel”

BioNanoScience
Sayali Kamble, Ganesh Bangale, Rutuja Deshmukh, Krishna Dawargave, Dipak Shingare, Omkar Suryawanshi, Kranti Kadam   +6 more
exaly   +2 more sources